IMWG 2014: Relapse and New Drugs
From the 2014 IMWG Conference Series Debate:
56th ASH Annual Meeting
December 8, 2014
San Francisco, CA, USA
Previous Post
Dr. Benedetto Bruno: on post-transplant minimal residual disease monitoring in myeloma (ASH 2014)
Next Post
Dr. Brittany Dykstra on diagnostic value of PET-CT in evaluation of smoldering myeloma (ASH 2014)




